Schonfeld Strategic Advisors LLC

Holdings History for Applied Therapeutics, Inc. - Common Stock, par value $0.0001 per share (APLT)

Symbol: APLT
Investment type: Equity / Common Stock, par value $0.0001 per share
Latest Disclosed Shares Owned: 4,676,097 shares
Security Ownership %: 3.3%

Shares, Excluding Options vs Price

Value, Excluding Options

Schonfeld Strategic Advisors LLC ownership in Applied Therapeutics, Inc. Common Stock, par value $0.0001 per share (APLT)

15 May 2025 - Schonfeld Strategic Advisors LLC has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 4,676,097 shares of Applied Therapeutics, Inc. Common Stock, par value $0.0001 per share (APLT). This represents 3.3% ownership of the company. In their previous filing dated 14 Feb 2025, Schonfeld Strategic Advisors LLC had reported owning 8,769,640 shares, indicating a decrease of +47%. .

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filing time
Schonfeld Strategic Advisors LLC	3.3%	-53%	$1,823,678	4,676,097	-4,093,543	-47%	$0.39	13G/A	31 Mar 2025	15 May 2025, 16:30
Schonfeld Strategic Advisors LLC	7.5%		$3,420,160	8,769,640			$0.39	13G	31 Dec 2024	14 Feb 2025, 16:15

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
30 Sep 2025		-0%	$0	0	-196,660	-100%	$0.10	Q3 2025
30 Jun 2025	0%	-0.01%	$61,178	196,660	-4,476,953	-96%	$0.31	Q2 2025
31 Mar 2025	0.02%	-0.01%	$2,284,928	4,673,613	-4,088,678		$0.49	Q1 2025
31 Dec 2024	0.05%	+0.05%	$7,502,272	8,762,291	+8,419,781	+2458%	$0.86	Q4 2024
30 Sep 2024	0.02%	-0.01%	$2,911,334	342,510	-191,219	-36%	$8.50	Q3 2024
30 Jun 2024	0.02%	-0.05%	$2,492,514	533,729	-1,302,913	-71%	$4.67	Q2 2024
31 Mar 2024	0.1%	+0.07%	$12,489,165	1,836,642	+1,345,151	+274%	$6.80	Q1 2024
31 Dec 2023	0.01%	+0%	$1,646,494	491,491	+34,091	+7.5%	$3.35	Q4 2023
30 Sep 2023	0.01%	+0.01%	$1,138,926	457,400	+457,400	NEW	$2.49	Q3 2023
30 Jun 2022		-0%	$0	0	-30,500	-100%	$0.10	Q2 2022
31 Mar 2022	0%	+0%	$65,000	30,500	+30,500	NEW	$2.13	Q1 2022

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.